Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study
Our study suggests the current cytology-based screening recommendation is cost-effective, but that primary HPV screening could be a cost-effective alternative to cotesting. To improve the cost-effectiveness of HPV-based screening, increased acceptance of the HPV test among targeted women is needed, as are alternative follow-up recommendations to limit the harms of high false-positive testing.
Authors
- Wendy A. Leyden
- Ran Zhao (ORCID: https://orcid.org/0000-0001-9539-8274)
- Michael Jonah Silverberg (ORCID: https://orcid.org/0000-0001-9322-1395)
- Megan J. Huchko (ORCID: https://orcid.org/0000-0002-4081-4768)
- Karen Smith‐McCune (ORCID: https://orcid.org/0000-0002-7141-3748)
- George F. Sawaya (ORCID: https://orcid.org/0000-0001-8243-4686)
- Erinn Sanstead (ORCID: https://orcid.org/0000-0003-1142-3212)
- Steven E. Gregorich
- Shalini Kulasingam
- Fernando Alarid‐Escudero (ORCID: https://orcid.org/0000-0001-5076-1172)
- Miriam Kuppermann (ORCID: https://orcid.org/0000-0002-8074-6923)
Institutions
- University of Minnesota (US)
- Kaiser Permanente (US)
- Duke University (US)
- University of California, San Francisco (US)
- Minnesota Department of Health (US)
- UPMC Center for High Value Health Care (US)
- Stanford University (US)
Publication Details
- Journal
- AIDS
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1097/qad.0000000000004002
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39